Edition:
United States

Profile: Evotec SE (EVTG.DE)

EVTG.DE on Xetra

22.08EUR
9:36am EDT
Change (% chg)

€0.01 (+0.05%)
Prev Close
€22.07
Open
€22.31
Day's High
€22.40
Day's Low
€22.01
Volume
511,043
Avg. Vol
984,094
52-wk High
€25.83
52-wk Low
€12.06

Evotec SE is a Germany-based drug discovery alliance and development partnership company. The Company focuses mainly on product approaches with a number of pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Company Address

Evotec SE

Essener Bogen 7
HAMBURG     22419
P: +4940.560810
F: +4940.56081222

Company Web Links